IL-6 As a Keystone Cytokine in Health and Disease

Overview

Journal Nat Immunol

Date 2015 Apr 22

PMID 25898198

Citations 1056

Authors

Christopher A Hunter

Simon A Jones

Affiliations

Soon will be listed here.

Abstract

Interleukin 6 (IL-6) has a broad effect on cells of the immune system and those not of the immune system and often displays hormone-like characteristics that affect homeostatic processes. IL-6 has context-dependent pro- and anti-inflammatory properties and is now regarded as a prominent target for clinical intervention. However, the signaling cassette that controls the activity of IL-6 is complicated, and distinct intervention strategies can inhibit this pathway. Clinical experience with antagonists of IL-6 has raised new questions about how and when to block this cytokine to improve disease outcome and patient wellbeing. Here we discuss the effect of IL-6 on innate and adaptive immunity and the possible advantages of various antagonists of IL-6 and consider how the immunobiology of IL-6 may inform clinical decisions.

Citing Articles

Circulating IL6 is involved in the infiltration of M2 macrophages and CD8+ T cells.

Huang J, Xiao R, Shi S, Li Q, Li M, Xiao M Sci Rep. 2025; 15(1):8681.

PMID: 40082587 PMC: 11906812. DOI: 10.1038/s41598-025-92817-9.

KDM4B modulates autocrine IL6 in erythroblasts to prevent ineffective erythropoiesis.

Peng Z, Su D, Xu J, Zhou L, Fu Z, Yang L Leukemia. 2025; .

PMID: 40074853 DOI: 10.1038/s41375-025-02559-w.

Identification and validation of the common pathogenesis and hub biomarkers in Papillary thyroid carcinoma complicated by rheumatoid arthritis.

Liu Y, Kong X, Sun Q, Cui T, Xu S, Ding C PLoS One. 2025; 20(3):e0317369.

PMID: 40063597 PMC: 11892850. DOI: 10.1371/journal.pone.0317369.

Advances in Interleukin-6 Family Cytokines and the Role in Respiratory Diseases.

Ji T, Huang G, Cao Y, Gao Y, Gao X J Inflamm Res. 2025; 18:3125-3141.

PMID: 40059944 PMC: 11889408. DOI: 10.2147/JIR.S508031.

The genetics of hyper IgE syndromes.

AlYafie R, Velayutham D, van Panhuys N, Jithesh P Front Immunol. 2025; 16:1516068.

PMID: 40040707 PMC: 11876172. DOI: 10.3389/fimmu.2025.1516068.

References

Lauder S, Jones E, Smart K, Bloom A, Williams A, Hindley J . Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology. Eur J Immunol. 2013; 43(10):2613-25. PMC: 3886386. DOI: 10.1002/eji.201243018. View

Masuda K, Ripley B, Nishimura R, Mino T, Takeuchi O, Shioi G . Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo. Proc Natl Acad Sci U S A. 2013; 110(23):9409-14. PMC: 3677444. DOI: 10.1073/pnas.1307419110. View

Neveu W, Allard J, Dienz O, Wargo M, Ciliberto G, Whittaker L . IL-6 is required for airway mucus production induced by inhaled fungal allergens. J Immunol. 2009; 183(3):1732-8. PMC: 2929571. DOI: 10.4049/jimmunol.0802923. View

Lattanzio G, Libert C, Aquilina M, Cappelletti M, Ciliberto G, Musiani P . Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. Am J Pathol. 1997; 151(3):689-96. PMC: 1857831. View

Baran P, Nitz R, Grotzinger J, Scheller J, Garbers C . Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling. J Biol Chem. 2013; 288(21):14756-68. PMC: 3663500. DOI: 10.1074/jbc.M113.466169. View

Woodcock K, Kierdorf K, Pouchelon C, Vivancos V, Dionne M, Geissmann F . Macrophage-derived upd3 cytokine causes impaired glucose homeostasis and reduced lifespan in Drosophila fed a lipid-rich diet. Immunity. 2015; 42(1):133-44. PMC: 4304720. DOI: 10.1016/j.immuni.2014.12.023. View

McGeachy M, Bak-Jensen K, Chen Y, Tato C, Blumenschein W, Mcclanahan T . TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007; 8(12):1390-7. DOI: 10.1038/ni1539. View

Lissilaa R, Buatois V, Magistrelli G, Williams A, Jones G, Herren S . Although IL-6 trans-signaling is sufficient to drive local immune responses, classical IL-6 signaling is obligate for the induction of T cell-mediated autoimmunity. J Immunol. 2010; 185(9):5512-21. DOI: 10.4049/jimmunol.1002015. View

Nagabhushanam V, Solache A, Ting L, Escaron C, Zhang J, Ernst J . Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma. J Immunol. 2003; 171(9):4750-7. DOI: 10.4049/jimmunol.171.9.4750. View

10.

DiCosmo B, Geba G, Picarella D, Elias J, Rankin J, Stripp B . Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest. 1994; 94(5):2028-35. PMC: 294635. DOI: 10.1172/JCI117556. View

11.

Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin J, Humphries S . The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998; 102(7):1369-76. PMC: 508984. DOI: 10.1172/JCI2629. View

12.

Garbers C, Thaiss W, Jones G, Waetzig G, Lorenzen I, Guilhot F . Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. J Biol Chem. 2011; 286(50):42959-70. PMC: 3234812. DOI: 10.1074/jbc.M111.295758. View

13.

Rosser E, Oleinika K, Tonon S, Doyle R, Bosma A, Carter N . Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. Nat Med. 2014; 20(11):1334-9. DOI: 10.1038/nm.3680. View

14.

Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y . Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood. 1993; 82(4):1120-6. View

15.

Skiniotis G, Boulanger M, Garcia K, Walz T . Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor. Nat Struct Mol Biol. 2005; 12(6):545-51. DOI: 10.1038/nsmb941. View

16.

Peters M, Jacobs S, Ehlers M, Vollmer P, Mullberg J, Wolf E . The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med. 1996; 183(4):1399-406. PMC: 2192475. DOI: 10.1084/jem.183.4.1399. View

17.

Grivennikov S, Karin E, Terzic J, Mucida D, Yu G, Vallabhapurapu S . IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009; 15(2):103-13. PMC: 2667107. DOI: 10.1016/j.ccr.2009.01.001. View

18.

Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T . Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986; 324(6092):73-6. DOI: 10.1038/324073a0. View

19.

Nurieva R, Chung Y, Hwang D, Yang X, Kang H, Ma L . Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity. 2008; 29(1):138-49. PMC: 2556461. DOI: 10.1016/j.immuni.2008.05.009. View

20.

Rohleder N, Aringer M, Boentert M . Role of interleukin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci. 2012; 1261:88-96. DOI: 10.1111/j.1749-6632.2012.06634.x. View